NCT05405595 2026-01-07ADG126 in Combination With Pembrolizumab in Patients With Advanced/Metastatic Solid TumorsAdagene IncPhase 1/2 Recruiting186 enrolled
NCT02665416 2020-04-07Study Evaluating the Safety, Pharmacokinetics (PK), Pharmacodynamics (PD), and Therapeutic Activity of Selicrelumab (RO7009789) With Vanucizumab or Bevacizumab in Participants With Metastatic Solid TumorsHoffmann-La RochePhase 1 Completed94 enrolled